Covington Capital Management’s ResMed RMD Stock Holding History

Covington Capital Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$81K	Buy	369 +16	+5%	+$3.64K	﹤0.01%	493
2022 Q2	$74K	Hold	353	–	–	﹤0.01%	503
2022 Q1	$86K	Buy	353 +350	+11,667%	+$84.7K	﹤0.01%	506
2021 Q4	$1K	Hold	3	–	–	﹤0.01%	981
2021 Q3	$1K	Buy	+3	New	+$820	﹤0.01%	991
2020 Q1	–	Sell	-27	Closed	-$4K	–	872
2019 Q4	$4K	Buy	+27	New	+$3.89K	﹤0.01%	817

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Covington Capital Management's RMD Position: Q3 2022 in Review

Covington Capital Management increased its ResMed (RMD) stake by 4.5% in Q3 2022, buying an estimated $3.64K and bringing the position to 369 shares worth $81K. The position accounts for ﹤0.01% of the portfolio, ranked #493.

Covington Capital Management first reported a position in RMD in Q4 2019 and has held it in 6 quarters since. The position peaked at $86K in Q1 2022. 668 funds tracked by Wall St. Rank hold RMD as of Q3 2022.

Covington Capital Management held 369 shares of ResMed worth $81K as of Q3 2022.
Covington Capital Management bought 16 ResMed shares in Q3 2022, an estimated $3.64K.
ResMed made up ﹤0.01% of Covington Capital Management's portfolio in Q3 2022, its #493 holding.
Covington Capital Management first reported a position in ResMed in Q4 2019 and has held it in 6 quarters since.
Covington Capital Management's ResMed position peaked at $86K in Q1 2022.
668 funds tracked by Wall St. Rank held ResMed as of Q3 2022.

Based on Covington Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.